Guaranteeing resilience in vaccine manufacturing
European Pharmaceutical Review
SEPTEMBER 28, 2023
There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.
Let's personalize your content